arrow
A

Alberto Órfão

universidad de salamanca
H指数:93
被引数:5.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)

多组学验证骨髓增生异常综合征(MDS)分子分类的临床相关性

2026-07-280
OAAI
Detailed immunophenotypic and genetic characterization of bone marrow clonal plasma cells and B-cells in early-stage monoclonal gammopathies

早期单克隆丙种球蛋白病患者骨髓克隆性浆细胞和B细胞的详细免疫表型及遗传学特征分析

2026-07-180
OA
Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing

利用下一代测序高灵敏度检测ctDNA,微创评估多发性骨髓瘤外周血可测量微小残留病

2026-06-180
OAAI
Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis

B细胞受体在慢性淋巴细胞白血病样单克隆B细胞淋巴增生病中的分子和功能表征

Leukemia
IF13.4
2026-01-070
OAAI
Comprehensive genetic characterization of adult BCR :: ABL1 -negative B-ALL by optical genome mapping and targeted NGS

通过光学基因组图谱和靶向NGS对成人BCR::ABL1阴性B-ALL的全面遗传表征

2026-01-010
OA
Impact of the kinetics of circulating anti-BCMA CAR-T cells and normal lymphocytes on the outcome of MM patients

循环抗BCMA CAR-T细胞和正常淋巴细胞动力学对MM患者预后的影响

2025-12-280
OAAI
Immune cell dynamics, cytokines, and extracellular vesicles in systemic inflammatory response syndrome (SIRS): a multiparametric analysis

免疫细胞动力学、细胞因子和细胞外囊泡在全身性炎症反应综合征(SIRS)中的作用:一项多参数分析

2025-11-230
OAAI
PD-1 Expression Promotes Immune Evasion in B-ALL

PD-1表达促进B-ALL免疫逃逸

2025-11-120
PRE
Immunological biomarkers of non-infectious complications and overall survival in common variable immunodeficiency

非感染性并发症的免疫学生物标志物及其在共同变异免疫缺陷病中的总生存期

2025-10-300
OAAI
T, B, and NK cells versus the primary immunodeficiency orientation tube for diagnostic screening of IEIs

T细胞、B细胞和NK细胞与原发性免疫缺陷定向管用于IEIs的诊断筛查

2025-10-160
PRE
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee

单克隆B细胞淋巴增多症(MBL)的最新生物学、进展和临床管理:Intercepting Blood Cancers Workshop Committee的共识报告

2025-08-290
OAAI
Improved diagnostic screening and classification of clonal mast cell diseases by ultrasensitive KIT p.D816V detection

通过超高灵敏度KIT p.D816V检测改进克隆性肥大细胞疾病的诊断筛查和分类

Blood
IF23.1
2025-08-180
OA
CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progression

分泌CD19 T细胞结合剂的CD22 CAR-T细胞,用于改善B细胞急性淋巴细胞白血病进展的控制

2025-04-300
OA
Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study

使用标准化的12色流式细胞术评估CD19靶向治疗后B细胞前体急性淋巴细胞白血病中的微小残留病灶:一项EuroFlow研究

2025-04-130
OAAI
Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia

新型流式细胞术抗体组合与专用分析算法,用于慢性淋巴细胞白血病的全自动标准化微小残留病检测

2025-01-250
OAAI
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM
2024-12-012
OAAI
Integrative single-cell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B cell neoplasias

CD19-CARpos和CARneg T细胞的整合单细胞多组学提示b细胞肿瘤中免疫治疗反应的驱动因素

2024-11-010
OAAI
Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials
2024-08-080
OAAI